Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-24 @ 11:58 PM
NCT ID:
NCT06654258
Eligibility Criteria:
Inclusion Criteria:
* Young adults between the ages of 18 and 39
* Histologically confirmed diagnosis of cancer (except basal cell skin carcinoma)
* For patients with solid tumors, patients must be within 12-weeks of current cancer diagnosis upon enrollment and currently receiving curative treatment (i.e., surgery and/or chemotherapy and/or radiation therapy; surgery-only patients must be within 6-weeks of surgery at time of enrollment). For patients with hematological cancers, there is no requirement for time since diagnosis, provided they are receiving treatment, including stable maintenance management.
* Able to provide informed consent and fluent in English for completion of study questionnaires
* Residing in the USA
* Internet access
* Own a smartphone with an active data plan or wi-fi
* Have a personal email address
Exclusion Criteria:
* Unable to provide informed consent
* Not currently engaging in curative cancer treatment(s) (i.e., awaiting treatment initiation, completed curative treatment(s))
* Currently receiving end-of-life palliative care or hospice care
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
39 Years
Study:
NCT06654258
Study Brief:
Protocol Section:
NCT06654258